All terms in GO
| Label | Id | Description |
|---|---|---|
| interleukin-1 beta production | GO_0032611 | [The appearance of interleukin-1 beta due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.] |
| inflammatory response | GO_0006954 | [The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.] |
| positive regulation of interleukin-1 beta biosynthetic process | GO_0050725 | [Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-1 beta.] |
| positive regulation of interleukin-1 beta production | GO_0032731 | [Any process that activates or increases the frequency, rate, or extent of interleukin-1 beta production.] |
| positive regulation of interleukin-1 alpha biosynthetic process | GO_0050726 | [Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-1 alpha.] |
| positive regulation of interleukin-1 alpha production | GO_0032730 | [Any process that activates or increases the frequency, rate, or extent of interleukin-1 alpha production.] |
| negative regulation of cytolysis by symbiont of host cells | GO_0001899 | [Any process in which an organism stops, prevents, or reduces the frequency, rate or extent of cytolysis by that organism of cells in its host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.] |
| negative regulation of cytolysis in other organism involved in symbiotic interaction | GO_0051803 | [Any process in which an organism stops, prevents, or reduces the frequency, rate or extent of cytolysis by that organism of cells in a second organism, where the two organisms are in a symbiotic interaction.] |
| cytolysis in other organism involved in symbiotic interaction | GO_0051801 | [The killing by an organism of a cell in a second organism by means of the rupture of cell membranes and the loss of cytoplasm, where the two organisms are in a symbiotic interaction.] |
| negative regulation of peptidyl-tyrosine phosphorylation | GO_0050732 | [Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.] |
| regulation of cytolysis in other organism involved in symbiotic interaction | GO_0051802 | [Any process in which an organism modulates the frequency, rate or extent of the cytolysis by that organism of cells in a second organism, where the two organisms are in a symbiotic interaction.] |
| RS domain binding | GO_0050733 | [Interacting selectively and non-covalently with an RS domain of a protein; RS domains are usually highly phosphorylated and characterized by the presence of arginine (R)/serine (S) dipeptides. The RS domain promotes protein-protein interactions and directs subcellular localization and, in certain situations, nucleocytoplasmic shuttling of individual SR proteins. They also play a role in splicing.] |
| hydroxycinnamoyltransferase activity | GO_0050734 | [Catalysis of the transfer of a hydroxycinnamoyl group to an acceptor molecule.] |
| autolysis | GO_0001896 | [A programmed cell death process observed in bacteria and filamentous fungi and leading to spontaneous death by lysis. Examples are lysis of the mother cell during sporulation of Bacillus subtilis and self-degradation of fungal cells in Aspergillus nidulans. Autolysis is also involved in bacterial biofilm formation.] |
| N-malonyltransferase activity | GO_0050735 | [Catalysis of the transfer of a malonyl group to a nitrogen atom on the acceptor molecule.] |
| malonyltransferase activity | GO_0016420 | [Catalysis of the transfer of a malonyl (HOOC-CH2-CO-) group to an acceptor molecule.] |
| maternal placenta development | GO_0001893 | [Maternally driven process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin.] |
| in utero embryonic development | GO_0001701 | [The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.] |
| O-malonyltransferase activity | GO_0050736 | [Catalysis of the transfer of a malonyl group to an oxygen atom on the acceptor molecule.] |
| O-hydroxycinnamoyltransferase activity | GO_0050737 | [Catalysis of the transfer of a hydroxycinnamoyl group to an oxygen atom on the acceptor molecule.] |